CorMedix Inc
Cerrado
SectorSanidad
8.72 -2.13
Resumen
Variación precio
24h
Mínimo
8.71
Máximo
8.81
Ingresos | 25M 39M |
|---|---|
Ventas | -1.2M 127M |
P/B Media del Sector | 3.936 49.052 |
BPA | 0.35 |
Margen de beneficios | 30.293 |
Empleados | 191 |
EBITDA | 7.7M 74M |
Recomendaciones | Compra Fuerte |
|---|---|
Estimación a 12 Meses | +63.04% upside |
Próximas Ganancias | 6 ago 2026 |
|---|
Capitalización Mercado | 69M 670M |
|---|---|
Apertura anterior | 10.85 |
Cierre anterior | 8.72 |
Noticias sobre sentimiento de mercado
By Acuity
67%
33%
302 / 342 Clasificación en Healthcare
CorMedix Inc Gráfico
Resultados pasados no son un indicador fiable de resultados futuros.
Acerca de CorMedix Inc
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
